Irritable Bowel Syndrome
📧 Sign up to get email alerts when something new happens for Irritable Bowel Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-04-05Clinical Trial Update: Exploratory Clinical Study to Evaluate the Optimal Dosage of Mosapride and Probiotics in Irritable Bowel Syndrome Without Predominant Diarrhea [Phase 2]
Phase 2 exploratory trial update reporting completion of a study to determine the optimal dosage of mosapride with probiotics for irritable …
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Completed the LOTRONEX (alosetron) trial for severe diarrhea-predominant irritable bowel syndrome (IBS-D) sponsored by Prometheus Laboratori…
-
CLINICAL_TRIALS trial_result · 2013-03-21Clinical Trial Update: Effect of Hypnotherapy and Educational Intervention in Irritable Bowel Syndrome [NA]
A completed clinical trial evaluated the impact of hypnotherapy combined with an educational intervention on Irritable Bowel Syndrome outcom…
-
CLINICAL_TRIALS trial_result · 2013-03-13Clinical Trial Update: Effect of a Cannabinoid Agonist on Colonic Sensory Functions in Patients With Irritable Bowel Syndrome [Phase 2]
A Phase 2 clinical trial evaluating a cannabinoid agonist's effect on colonic sensory function in patients with Irritable bowel syndrome, wi…
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: Trial of Chinese Prescription Shugan Decoction on Irritable Bowel Syndrome（Diarrhea Type） [NA]
A completed clinical trial evaluated the Chinese medicine Shugan Decoction for diarrhea-predominant irritable bowel syndrome.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2013-03-04Clinical Trial Update: Lactulose and Glucose Breath Tests as Predictors of Clinical Benefit From Rifaximin in Irritable Bowel Syndrome
A clinical trial update evaluating whether lactulose and glucose breath tests can predict which Irritable Bowel Syndrome patients will benef…
-
CLINICAL_TRIALS trial_result · 2013-03-01Clinical Trial Update: Repetitive Transcranial Magnetic Stimulation in Irritable Bowel Syndrome [Phase 2]
A Phase 2 clinical trial evaluating repetitive transcranial magnetic stimulation as a treatment for Irritable Bowel Syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Cognitive Behavioral Therapy With Our Without Exposure Therapy for Irritable Bowel Syndrome [NA]
A completed clinical trial from Karolinska Institutet evaluated cognitive behavioral therapy, with or without exposure therapy, for irritabl…
-
CLINICAL_TRIALS research · 2013-02-06Clinical Trial Update: Abdominal Symptom Phenotype Study in Children
A completed pediatric clinical trial investigating abdominal symptom phenotypes in children with irritable bowel syndrome.
-
CLINICAL_TRIALS trial_result · 2013-01-29Clinical Trial Update: The Effect of a Multispecies Probiotic on Hypersensitivity in Irritable Bowel Syndrome (IBS) Patients [NA]
A completed ClinicalTrials.gov study evaluated the effect of a multispecies probiotic on hypersensitivity in patients with irritable bowel s…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Physical Activity in IBS - a Long Term Follow up [NA]
Clinical trial update reporting the long-term follow-up results of a study examining physical activity in irritable bowel syndrome.
-
CLINICAL_TRIALS trial_result · 2013-01-21Clinical Trial Update: Manipulation of Visceral Hypersensitivity With Probiotic Bacteria in Irritable Bowel Syndrome [Phase 4]
Phase 4 trial evaluating manipulation of visceral hypersensitivity with probiotic bacteria in irritable bowel syndrome has completed.
-
FDA approval · 2012-12-31FDA Approved: DICYCLOMINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for dicyclomine hydrochloride by Actavis Pharma, Inc., supporting continued availability under the a…
-
FDA approval · 2012-12-28FDA Approved: DICYCLOMINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for dicyclomine hydrochloride from Aurobindo Pharma Limited, enabling expanded approval of the g…
-
CLINICAL_TRIALS trial_result · 2012-12-06Clinical Trial Update: Ayurvedic Herbs in Diarrhea Predominant Irritable Bowel Syndrome [NA]
A completed clinical trial evaluating Ayurvedic herbs for diarrhea-predominant irritable bowel syndrome.
-
CLINICAL_TRIALS trial_result · 2012-11-09Clinical Trial Update: Gut Peptides and Intestinal Permeability in Celiac Disease and Irritable Bowel Syndrome
This update reports the completion of a clinical trial investigating gut peptides and intestinal permeability in individuals with celiac dis…
-
CLINICAL_TRIALS trial_result · 2012-10-16Clinical Trial Update: Saccharomyces Boulardii in Irritable Bowel Syndrome [Phase 3]
A Phase 3 clinical trial evaluating Saccharomyces boulardii for diarrhea-predominant irritable bowel syndrome has completed.
-
CLINICAL_TRIALS research · 2012-10-03Clinical Trial Update: Probiotics for the Treatment of Irritable Bowel Syndrome in Celiac Patients [NA]
An ongoing clinical trial conducted by the University of Bari is evaluating probiotics for treating irritable bowel syndrome in patients wit…
-
EMA approval · 2012-09-21European Medicines Agency recommends authorisation of first medicine specifically for irritable bowel syndrome
The EMA recommends authorisation of the first medicine specifically for irritable bowel syndrome, marking a milestone for IBS treatment opti…
-
CLINICAL_TRIALS trial_result · 2012-08-30Clinical Trial Update: Effects of an Integrative Treatment Model to Reduce Anxiety and Depression in Minor Mental Health Problems and Medically Unexplained Symptoms [NA]
This clinical trial update reports completion of a study evaluating an integrative treatment model to reduce anxiety and depression in indiv…
-
CLINICAL_TRIALS trial_result · 2012-07-20Clinical Trial Update: An Open-Label Study of Two Formulations of LX1033 in Healthy Human Subjects [Phase 1]
This Phase 1 open-label study evaluated two formulations of LX1033 in healthy subjects to assess safety and tolerability. The study also col…
-
CLINICAL_TRIALS trial_result · 2012-07-11Clinical Trial Update: Changes in Gastrointestinal Microbiota Using VSL#3 in Patients With IBS-D [Phase 4]
This clinical trial update describes changes in the gastrointestinal microbiota of IBS patients treated with the probiotic VSL#3 in a Phase …
-
CLINICAL_TRIALS research · 2012-07-10Clinical Trial Update: The Effects of Lactose Intolerance on Gastrointestinal Function and Symptoms in a Chinese Population [NA]
A clinical trial update notes an ongoing study on how lactose intolerance affects gastrointestinal function and symptoms in a Chinese popula…
-
CLINICAL_TRIALS research · 2012-07-03Clinical Trial Update: Assessment of Small Intestinal Bowel Epithelial Gaps in Irritable Bowel Syndrome
A clinical trial update from Shandong University assessing small intestinal epithelial gaps in irritable bowel syndrome and inflammatory bow…
-
CLINICAL_TRIALS trial_result · 2012-07-02Clinical Trial Update: Cheno Effect on Transit in Health and IBS-C [Phase 2]
Phase 2 trial evaluating the effect of Cheno on intestinal transit in healthy volunteers and patients with constipation-predominant irritabl…